Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05169151

Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study

A Study to Digitally Phenotype Mobility and Physical Activity in Adolescent and Young Adult (AYA) Patients at Risk for Cardiovascular Morbidity and Frailty: MOBILE AYA

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
15 Years – 39 Years
Healthy volunteers
Not accepted

Summary

This study attempts to learn more about the activity levels of adolescent and young adult (AYA) cancer patients or survivors at risk for cardiovascular morbidity and frailty by using a smartphone application called Beiwe. Collecting activity level data on AYA cancer patients or survivors may help patients achieve better quality of life.

Detailed description

PRIMARY OBJECTIVES: I. To characterize patient mobility over time based upon smartphone sensor data, including dwell time at home and hospital, as well as time spent away from home or hospital, considering patients actively undergoing treatment (time referenced to treatment start) separately from those following treatment (time referenced to treatment end). II. To characterize patient physical activity over time based upon smartphone sensor data, during and following treatment (separately), including inactivity time and activity level, at home and hospital and away from home or hospital, considering patients actively undergoing treatment (time referenced to treatment start) separately from those following treatment (time referenced to treatment end). SECONDARY OBJECTIVES: I. To characterize patient mobility over time based upon smartphone sensor data, including dwell time at home and hospital, as well as time spent away from home or hospital, considering patients actively undergoing treatment (time referenced to treatment start) separately from those following treatment (time referenced to treatment end), grouped by disease and treatment (chemotherapy, radiotherapy), controlling for age, sex, race, and body mass index (BMI). II. To characterize patient physical activity over time based upon smartphone sensor data during and following treatment (separately), including inactivity time and activity level, at home and hospital and away from home or hospital, considering patients actively undergoing treatment (time referenced to treatment start) separately from those following treatment (time referenced to treatment end), grouped by disease and treatment (chemotherapy, radiotherapy), controlling for age, sex, race, and BMI. OUTLINE: Patients utilize smartphone application to monitor physical activity and mobility up to 180 days during treatment or post-treatment.

Conditions

Interventions

TypeNameDescription
OTHERSmartphone ApplicationUtilize smartphone application

Timeline

Start date
2022-02-17
Primary completion
2023-04-18
Completion
2023-04-18
First posted
2021-12-23
Last updated
2023-04-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05169151. Inclusion in this directory is not an endorsement.